Back To Search Results

Antepartum Care

Editor: Peter L. Hong Updated: 8/8/2023 1:31:50 AM


Antepartum care, also referred to as prenatal care, consists of the all-encompassing management of patients throughout their pregnancy course. Antepartum care has become the most frequently utilized healthcare service within the United States, averaging greater than 50 million visits annually. After the first positive pregnancy test, care is typically sought by patients and begun after confirmed sonographic intrauterine pregnancy. The average number of visits ranges between twelve to seventeen visits, depending on the complexity of the pregnancy course.

The prenatal course is typically separated into trimesters, for which each of the three trimesters serves a specific purpose for maternal/fetal monitoring, gestation-specific examinations and laboratory work, and screening for potential pregnancy abnormalities. Traditionally, prenatal visit frequencies are typically scheduled at 4-week intervals until 28 weeks of gestation, at which time visits are scheduled every 2 weeks until 36 weeks of gestation, followed by weekly visits until delivery. Visits may be adjusted to more frequent follow-ups when high-risk pregnancy complications are present, when pertinent lab values must be reviewed, or if patients require closer monitoring for risk factors.[1][2][3]

With the increasing focus beginning in the early 1990s on preventing maternal and fetal morbidity and mortality, great efforts have been made to improve access to quality antepartum care to low socio-economic and minority populations. Although still prevalent despite efforts, the growing disparities between minority populations (specifically among Hispanics and African Americans) are rooted in lack of access and complex obstetric and medical risk factors leading to poor obstetric outcomes. Thus, an adequate evaluation of a patient’s medical history, related risk factors, and potential obstacles to healthcare must be attained, followed by a patient-centered discussion regarding the potential prenatal plan of care.[1][2][3]


Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care


First Trimester Antepartum Care (0-14 6/7 weeks)

First trimester antepartum care most commonly begins with an initial prenatal visit, after the development of symptoms, a positive pregnancy test, and confirmed intrauterine gestation via sonography. Patients with early pregnancies may present with any combination of signs and symptoms or might be completely asymptomatic. The most common presenting complaint of patients is an abrupt cessation of the menstrual cycle in previously healthy women of reproductive age with regular menstrual cycles. Although this is a common presenting complaint, menstrual cycle variation among women of varying ages or underlying gynecologic conditions also means amenorrhea cannot reliably be utilized as the only method of diagnosis of pregnancy. Patients may also present with complaints of breast pain or swelling, often less commonly reported by multiparous patients. 

Sonography, specifically transvaginal sonography, plays an essential role in identifying and establishing gestational age and confirms the location of the pregnancy. Intrauterine pregnancies are confirmed by the presence of a gestation sac within the endometrial cavity, typically identified at 4 to 5 weeks gestation, along with a visualization of a yolk sac, typically seen by 5 weeks gestation. With this confirmation, and at about 6 weeks gestation, cardiac activity may be noted.

Several major tasks must be accomplished during this initial visit, including establishing the baseline medical condition of the patient and fetus, proper gestational age and dating, and planning the intended course of obstetric care with the patient. Within the first visit, a complete history should be taken, including a detailed history of past medical problems that may be of concern during pregnancy, previous surgeries, and detailed past obstetric and gynecologic history for foreseeable complications. Current issues and complaints should also be addressed.

A complete physical examination should also be performed, including complete vital signs, maternal weight, and pelvic/cervical examination, fundal height, and fetal heart rate. Laboratory tests should also be collected and completed during this first visit. These include a complete blood count (CBC), complete metabolic panel (CMP), blood type and Rh factor testing with antibody screen, urine analysis, urine culture, pap smear screening, rubella serology, syphilis serology, gonorrhea, and chlamydia screening, Hepatitis B serology, and HIV serology. These results should be followed up promptly so as to begin necessary adjustments to prenatal care, repeat laboratory testing, or initiate treatment or a higher level of care.  During the first trimester, fetal nuchal translucency sonography and fetal aneuploidy screening may be performed between 11 and 14 weeks gestation and again during the second trimester depending on the modality of fetal aneuploidy testing utilized.[4][5][6][7][8]

Second Trimester Antepartum Care (15 0/7 - 28 6/7 weeks)

In the second trimester, antepartum care consists of updated histories with each visit, including reviewing current pregnancy-related issues and a review of newly occurring issues. This includes assessing possible symptoms such as headaches, altered vision, abdominal pain, nausea or vomiting, vaginal bleeding, leakage of fluid, or dysuria. During early second trimester gestations, patients may begin to endorse the perception of fetal movement. This is typically found at around 16 to 18 weeks gestation, or even up to 20 weeks gestation, in primigravida patients and varies in the detection based on maternal factors such as body habitus. 

Care also includes repeat blood pressure recordings, maternal weight, fundal height, and fetal heart rate. Fetal heart rates can be detected via Doppler ultrasound, in nonobese patients, at as early as 10 weeks gestation. Because the second trimester encompasses a vast majority of the rapid fetal growth period, several essential screening and laboratory tests are collected during this trimester. Earlier in the second trimester, the second portion of combined-trimester fetal aneuploidy testing or single-test quadruple maternal screening is collected between 16 to 20 weeks gestation. In addition to this, fetal sonography for the anatomic survey is performed during 18 to 20 weeks gestation.

Gestational diabetic screening is also an essential component of second-trimester testing via a 50-gram glucose tolerance test. This is typically collected between 24 to 28 weeks of gestation. Tdap vaccinations are also routinely administered during this timeframe. If patients have a known Rh-negative status, Rhogam is administered at 28 weeks. Patients during this trimester are also counseled at around 28 weeks gestation to begin self-monitoring of fetal movements equating to 10 movements within 2 hours, also known as “fetal kick counts.”[9][10][11]

Third Trimester Antepartum Care (29 0/7- 41 6/7 weeks)

The third trimester of antepartum care consists of the final preparations, screenings, necessary treatments, and counseling to facilitate safe and timely delivery and improved maternal and fetal outcomes. As with second-trimester visits, antepartum care in the third trimester consists of updated histories with each visit, reviewing current pregnancy-related issues and reviewing newly occurring issues. Review of new symptoms such as headaches, altered vision, abdominal pain, nausea or vomiting, vaginal bleeding, leakage of fluid, or dysuria should be discussed. If present, appropriate physical examination or laboratory testing should be completed. And, as performed in other visits, blood pressure recordings, maternal weight, fundal height, and fetal heart rate should be obtained.

Between 36 to 37 weeks gestation, third-trimester laboratory testing is typically collected in uncomplicated prenatal care. These include repeat complete blood count to address and correct anemia or thrombocytopenia prior to delivery, Hepatitis B surface antigen testing, gonorrhea and chlamydia screening, HIV screening, and Group B Streptococcal screening. During late third trimester visits, patients typically return for weekly visits to assess for signs of early labor, fetal distress, or maternal complaints.

Patients may also require a physical examination, including cervical examination, sonography to assess for estimated fetal weight and amniotic fluid index, or nonstress tests to examine fetal status. If there are abnormalities, other pregnancy-related, or maternal-related medical conditions present, patients may require induction of labor or imminent delivery depending on the circumstance and severity.[12][13]

Issues of Concern

Several issues of concern may arise during the course of antepartum care. While serious medical conditions pose a risk and concern to prenatal management (discussed in other articles), most areas of concern in day-to-day pregnancy issues also comprise a significant amount of patient complaints. Therefore, recognition of these concerns and timely intervention is an essential contributor to adequate antepartum care. 

Nausea and Vomiting

Nausea and vomiting are among the most common complaints of pregnant patients within the first trimester of pregnancy, and is thought to be multifactorial and more directly caused by rapidly increasing level of pregnancy-related hormones such as beta HCG, estrogen, progesterone, placental growth hormone, leptin, and several others. Patients may experience varying degrees of nausea or vomiting throughout the antepartum course. Severe cases may require hospitalization and workup for more serious causes, such as hyperemesis gravidarum, identified by severe dehydration, accompanied by acid-base and electrolyte abnormalities. Patients typically state symptoms present prominently after the first missed menstrual cycle and may continue up to 16 weeks of gestation and up to 22 weeks gestation in rare cases. Symptoms are typically perceived to be more severe during early waking hours. Patients experiencing these issues may receive relief from several different interventions. First, patients may attempt to portion smaller, more frequent meals, ginger into their diets, or supplement medications. Patients may require Vitamin B6 supplementation with Doxylamine or antiemetics such as H1-receptor antagonists.[14][15]

Musculoskeletal Back Pain

Patients during the antepartum course may also have significant complaints of back and lower lumbar pain, most commonly in the third trimester of pregnancy and caused by the increasing size of the gravid uterus and alignment distortion. This is typically worsened by walking significant distances, intense bending forward, or lifting moderately weighted objects. Severe cases of back pain may warrant orthopedic evaluation. Management of back pain includes rest, heating pads, back braces, and analgesics.[16][17][18]

Weight Gain

Weight gain during pregnancy should be discussed with patients and assessed based on pre-pregnancy BMI and individual risk factors, with an increased focus on obesity. Obesity’s association with fetal macrosomia, gestational diabetes, gestational hypertension, preeclampsia, rate of cesarean sections, and other pregnancy complications requires early intervention and counseling of patients beginning in early antepartum care. Pre-pregnancy BMI categories allow for stratification of the total weight gain throughout pregnancy recommendation for underweight patients (BMI <18.5) to be a 28 to 40 lb (12.7 18.1 kg) to total weight gain, normal weight (BMI: 18.5 to 24.9) to be a 25 to 35 lb (11.3 to 15.9 kg) total weight gain, overweight (BMI: 25.0 to 29.9) to be a 15 to 25 lb (6.8 to 11.3 kg) total weight gain, and obese (BMI great or equal to 30.0) to be an 11 to 20 lb (5 to 9 kg) total weight gain. The emphasis during antepartum care and weight gain is currently focused on the obese population, given the significantly increased risk for gestational diabetes, macrosomia, gestational hypertension, preeclampsia, and cesarean delivery, and other antepartum and intrapartum complications.[19][20][21]

Smoking, Alcohol, and Illicit Drugs Use 

Although the overall prevalence of cigarette smoking during pregnancy has decreased significantly throughout the United States, there continues to be a prevalence of twelve to thirteen percent of women who endorse cigarette use during the antepartum period. These patients typically tend to be younger in age, have completed fewer years of education, and are of lower socioeconomic status. During the antepartum course, it is essential to identify patients who endorse smoking, counsel patients extensively regarding risk factors associated with cigarette use during pregnancy, and implement a quitting plan with the identification of foreseeable roadblocks and obstacles to doing so. Cigarette smoke is fetotoxic due to the vasoactive effects leading to its substances leading to a marked reduction in oxygen levels. Effects of decreased oxygen levels may lead to cardiac anomalies, gastroschisis, hydrocephaly, microcephaly, omphalocele, cleft lip, and palate, or limb anomalies. These effects are noted to be dose-dependent. Risks associated with cigarette smoke use and exposure in the antepartum period also include spontaneous abortions, fetal growth reduction, preterm delivery, and placental abnormalities, like placental abruption or placenta previa.[22]

Like tobacco, alcohol use during pregnancy, while decreasing in prevalence, is still prevalent amongst eight to thirty percent of pregnancies in the United States. Alcohol exposure in-utero has been established as the leading cause of non-genetically linked mental retardation, along with a constellation of presenting defects that together are referred to as Fetal Alcohol Syndrome. These include notable central nervous system abnormalities (neurologic, functional, and structural dysfunction), growth restriction, notable dysmorphic facial features (short palpebral fissures, smooth philtrum, and thinned vermilion border), and other anomalies (cardiac, skeletal, renal, auditory, ophthalmologic, etc.). While the dose-effect correlation between alcohol use in pregnancy and fetal defects is unknown, several studies show an increased risk among those exposed to excessive binge-drinking behavior.[23][24]

Illicit drug use during pregnancy is also of major concern to both maternal and fetal outcomes. With exposure rates as high as ten percent, assessing patients using recreational drugs must be completed in all pregnant patients. The use of drugs poses a unique risk when considering outcomes and fetal effects, given the multiple variables typically associated with those using drugs. These include younger patient populations, low socioeconomic status, polysubstance abuse, mental health issues, infectious diseases, and other social issues, which may complicate the picture of diagnosis and management. The greatest risk of illicit drug use in pregnancy also lies with the toxic and teratogenic effects of additives and impurities found in several street drugs. Effects of recreational drug use include, but are not limited to, fetal growth restriction, facial defects, cardiovascular, renal, and urinary abnormalities, behavioral abnormalities, and complications of fetal withdrawal (i.e., seizures, central nervous system defects).[25][26]

Work & Employment

With more than half of pregnant women working from conception until delivery, employment during the antepartum course is another common area of concern for patients. According to the Family and Medical Leave Act, pregnant employees must be granted at least twelve weeks of unpaid leave from employment for delivery and newborn care. As per the American College of Obstetrics and Gynecology, pregnant women may continue employment until labor begins in the absence of obstetric complications.

Despite these recommendations, some work may increase the risk of complications to pregnant patients, including employment that requires strenuous heavy lifting and long work hours. These demanding conditions may place additional stress on the patient as well as the pregnancy course, leading to complications such as gestational hypertension with an increased risk of the development of preeclampsia, preterm premature rupture of membranes, preterm labor and delivery, and fetal growth restrictions. It is acceptable to counsel patients with significant obstetric histories of these complications on the added risk of strenuous workplaces on the antepartum course.[27][28][29]


With the emphasis on promoting healthy lifestyles during antepartum care, patients may have specific concerns regarding exercise safety during pregnancy. The American College of Obstetrics and Gynecology recommends that after thorough clinical evaluation and with no contraindications, pregnant women should be encouraged to participate in regular, moderate-intensity physical activity in regular, moderate-intensity physical activity for at least thirty minutes or greater per day. Relative contraindications are noted as follows: heavy smoking, poorly controlled disorders such as seizure disorder, hyperthyroidism, Type 1 diabetes, or hypertension, extreme weights including morbid obesity or underweight, intrauterine growth restriction, chronic bronchitis, unevaluated maternal cardiac arrhythmia, history of severely sedentary lifestyle, symptomatic or severe anemia, or heavy smoking.

Absolute contraindications as as follows: incompetent cervix or cerclage, multifetal gestation pregnancy with risk of preterm labor, persistent second or third trimester vaginal bleeding, preterm labor during in the pregnancy, placenta previa present after 26 weeks of gestation, rupture of membranes, preeclampsia or pregnancy-induced hypertension, significant heart disease, or restrictive lung disease. Specific physical activities and intensity of those activities should be reviewed. Those activities in which the risk of trauma to the abdomen or falls are increased should be discouraged.[30][31][32]


The American College of Obstetrics and Gynecology states that pregnant women may safely travel until 36 weeks of gestation provided there are no complications. Modern, adequately pressurized aircraft pose no harm to pregnant patients or fetuses. Patients are advised to ambulate every hour while on long flights to prevent thromboembolism and wear seat belts throughout the flight. Seat belt safety in regards to automobile travel should be discussed with all pregnant patients during antepartum care. Specifically, correct placement of seatbelts via three-point restraints where the shoulder portion of the strap should be firmly positioned between the breasts and bottom portion should safely be positioning under the abdomen and across the upper portion of the thigh. Both should be positioned across the body tightly, and airbags should always be present in vehicles and utilized in the event of a high-impact accident.[33][34][35]

Clinical Significance

The totality of antepartum care is an intricate balance of maternal and fetal management aimed to prevent significant maternal and fetal morbidity and mortality and provide support throughout the prenatal course. Close follow-up with timely review of new complaints or issues, significant physical exam, sonography, and laboratory findings facilitate the necessary interventions. These may include escalation of care to more frequent antepartum care visits, close follow-up by maternal-fetal medicine specialists, or potential early delivery depending on the gestational age, clinical picture, and potential improvement of outcomes.

While all of these interventions can be implemented with relative ease, major obstacles do exist to achieving this. The main concern for practitioners is patient compliance with visits, specifically in low socioeconomic or minority populations. Obstacles, such as access to prenatal facilities, transportation, or proper understanding of risk factors, all play a role in delayed intervention. Because of this, it is essential for the antepartum care team to identify these obstacles early in the prenatal course so as to preemptively find solutions to potential obstacles.[1][2][3]

Enhancing Healthcare Team Outcomes

During the antepartum course, the care and management of patients serve significant challenges and obstacles, given the complexity of caring for both the patient and fetus. Because of this dual perspective, a team-directed approach of care by physicians, nurses, pharmacists, and healthcare aids is essential for improving maternal and fetal outcomes. This begins with adequate antepartum or prenatal care to ensure patients feel supported and informed. This also includes early detection and acknowledgments of patient complaints, signs, and symptoms of early disease processes, vital signs, laboratory values, and antepartum and prenatal care goals.



Byerley BM, Haas DM. A systematic overview of the literature regarding group prenatal care for high-risk pregnant women. BMC pregnancy and childbirth. 2017 Sep 29:17(1):329. doi: 10.1186/s12884-017-1522-2. Epub 2017 Sep 29     [PubMed PMID: 28962601]

Level 3 (low-level) evidence


Sharma J, O'Connor M, Rima Jolivet R. Group antenatal care models in low- and middle-income countries: a systematic evidence synthesis. Reproductive health. 2018 Mar 5:15(1):38. doi: 10.1186/s12978-018-0476-9. Epub 2018 Mar 5     [PubMed PMID: 29506531]

Level 1 (high-level) evidence


Gennaro S, Melnyk BM, OʼConnor C, Gibeau AM, Nadel E. Improving Prenatal Care for Minority Women. MCN. The American journal of maternal child nursing. 2016 May-Jun:41(3):147-53. doi: 10.1097/NMC.0000000000000227. Epub     [PubMed PMID: 26854915]


Lou S, Frumer M, Schlütter MM, Petersen OB, Vogel I, Nielsen CP. Experiences and expectations in the first trimester of pregnancy: a qualitative study. Health expectations : an international journal of public participation in health care and health policy. 2017 Dec:20(6):1320-1329. doi: 10.1111/hex.12572. Epub 2017 May 18     [PubMed PMID: 28521069]

Level 2 (mid-level) evidence


Carlson LM, Vora NL. Prenatal Diagnosis: Screening and Diagnostic Tools. Obstetrics and gynecology clinics of North America. 2017 Jun:44(2):245-256. doi: 10.1016/j.ogc.2017.02.004. Epub     [PubMed PMID: 28499534]


McClatchey T, Lay E, Strassberg M, Van den Veyver IB. Missed opportunities: unidentified genetic risk factors in prenatal care. Prenatal diagnosis. 2018 Jan:38(1):75-79. doi: 10.1002/pd.5048. Epub 2017 Apr 24     [PubMed PMID: 28384392]


Pontius E, Vieth JT. Complications in Early Pregnancy. Emergency medicine clinics of North America. 2019 May:37(2):219-237. doi: 10.1016/j.emc.2019.01.004. Epub     [PubMed PMID: 30940368]


American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 101: Ultrasonography in pregnancy. Obstetrics and gynecology. 2009 Feb:113(2 Pt 1):451-61. doi: 10.1097/AOG.0b013e31819930b0. Epub     [PubMed PMID: 19155920]


Moniz MH, Beigi RH. Maternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptance. Human vaccines & immunotherapeutics. 2014:10(9):2562-70. doi: 10.4161/21645515.2014.970901. Epub 2014 Oct 30     [PubMed PMID: 25483490]


Gupta Y, Kalra B. Screening and diagnosis of gestational diabetes mellitus. JPMA. The Journal of the Pakistan Medical Association. 2016 Sep:66(9 Suppl 1):S19-21     [PubMed PMID: 27582144]


Dall'Asta A, Lees C. Early Second-Trimester Fetal Growth Restriction and Adverse Perinatal Outcomes. Obstetrics and gynecology. 2018 Apr:131(4):739-740. doi: 10.1097/AOG.0000000000002548. Epub     [PubMed PMID: 29578967]


Newfield E. Third-trimester pregnancy complications. Primary care. 2012 Mar:39(1):95-113. doi: 10.1016/j.pop.2011.11.005. Epub     [PubMed PMID: 22309584]


Young JS, White LM. Vaginal Bleeding in Late Pregnancy. Emergency medicine clinics of North America. 2019 May:37(2):251-264. doi: 10.1016/j.emc.2019.01.006. Epub 2019 Mar 8     [PubMed PMID: 30940370]


. Practice Bulletin No. 153: Nausea and Vomiting of Pregnancy. Obstetrics and gynecology. 2015 Sep:126(3):e12-e24. doi: 10.1097/AOG.0000000000001048. Epub     [PubMed PMID: 26287788]


Borrelli F, Capasso R, Aviello G, Pittler MH, Izzo AA. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstetrics and gynecology. 2005 Apr:105(4):849-56     [PubMed PMID: 15802416]

Level 1 (high-level) evidence


George JW, Skaggs CD, Thompson PA, Nelson DM, Gavard JA, Gross GA. A randomized controlled trial comparing a multimodal intervention and standard obstetrics care for low back and pelvic pain in pregnancy. American journal of obstetrics and gynecology. 2013 Apr:208(4):295.e1-7. doi: 10.1016/j.ajog.2012.10.869. Epub 2012 Oct 23     [PubMed PMID: 23123166]

Level 1 (high-level) evidence


Norén L, Ostgaard S, Johansson G, Ostgaard HC. Lumbar back and posterior pelvic pain during pregnancy: a 3-year follow-up. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2002 Jun:11(3):267-71     [PubMed PMID: 12107796]

Level 2 (mid-level) evidence


Smith MW, Marcus PS, Wurtz LD. Orthopedic issues in pregnancy. Obstetrical & gynecological survey. 2008 Feb:63(2):103-11. doi: 10.1097/OGX.0b013e318160161c. Epub     [PubMed PMID: 18199383]


Kaiser L, Allen LH, American Dietetic Association. Position of the American Dietetic Association: nutrition and lifestyle for a healthy pregnancy outcome. Journal of the American Dietetic Association. 2008 Mar:108(3):553-61     [PubMed PMID: 18401922]


Catalano PM. Increasing maternal obesity and weight gain during pregnancy: the obstetric problems of plentitude. Obstetrics and gynecology. 2007 Oct:110(4):743-4     [PubMed PMID: 17906003]


Kiel DW, Dodson EA, Artal R, Boehmer TK, Leet TL. Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstetrics and gynecology. 2007 Oct:110(4):752-8     [PubMed PMID: 17906005]

Level 2 (mid-level) evidence


Honein MA, Paulozzi LJ, Watkins ML. Maternal smoking and birth defects: validity of birth certificate data for effect estimation. Public health reports (Washington, D.C. : 1974). 2001 Jul-Aug:116(4):327-35     [PubMed PMID: 12037261]


Abel EL, Hannigan JH. Maternal risk factors in fetal alcohol syndrome: provocative and permissive influences. Neurotoxicology and teratology. 1995 Jul-Aug:17(4):445-62     [PubMed PMID: 7565491]


. Committee opinion no. 496: At-risk drinking and alcohol dependence: obstetric and gynecologic implications. Obstetrics and gynecology. 2011 Aug:118(2 Pt 1):383-388. doi: 10.1097/AOG.0b013e31822c9906. Epub     [PubMed PMID: 21775870]

Level 3 (low-level) evidence


ACOG Committee on Health Care for Underserved Women, American Society of Addiction Medicine. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and gynecology. 2012 May:119(5):1070-6. doi: 10.1097/AOG.0b013e318256496e. Epub     [PubMed PMID: 22525931]

Level 3 (low-level) evidence


. Committee opinion no. 471: Smoking cessation during pregnancy. Obstetrics and gynecology. 2010 Nov:116(5):1241-4. doi: 10.1097/AOG.0b013e3182004fcd. Epub     [PubMed PMID: 20966731]


Higgins JR, Walshe JJ, Conroy RM, Darling MR. The relation between maternal work, ambulatory blood pressure, and pregnancy hypertension. Journal of epidemiology and community health. 2002 May:56(5):389-93     [PubMed PMID: 11964438]


[Limits of occlusal functional diagnosis in practice]., Reinhardt W,, Stomatologie der DDR, 1979 Apr     [PubMed PMID: 10725502]

Level 1 (high-level) evidence


Newman RB, Goldenberg RL, Moawad AH, Iams JD, Meis PJ, Das A, Miodovnik M, Caritis SN, Thurnau GR, Dombrowski MP, Roberts J, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Occupational fatigue and preterm premature rupture of membranes. National Institute of Child Health and Human Development Maternal-Fetal Medicine, Units Network. American journal of obstetrics and gynecology. 2001 Feb:184(3):438-46     [PubMed PMID: 11228500]

Level 2 (mid-level) evidence


Mota P, Bø K. ACOG Committee Opinion No. 804: Physical Activity and Exercise During Pregnancy and the Postpartum Period. Obstetrics and gynecology. 2021 Feb 1:137(2):376. doi: 10.1097/AOG.0000000000004267. Epub     [PubMed PMID: 33481514]

Level 3 (low-level) evidence


Clapp JF 3rd, Kim H, Burciu B, Lopez B. Beginning regular exercise in early pregnancy: effect on fetoplacental growth. American journal of obstetrics and gynecology. 2000 Dec:183(6):1484-8     [PubMed PMID: 11120515]

Level 1 (high-level) evidence


Duncombe D, Skouteris H, Wertheim EH, Kelly L, Fraser V, Paxton SJ. Vigorous exercise and birth outcomes in a sample of recreational exercisers: a prospective study across pregnancy. The Australian & New Zealand journal of obstetrics & gynaecology. 2006 Aug:46(4):288-92     [PubMed PMID: 16866788]


. ACOG Committee Opinion No. 746: Air Travel During Pregnancy. Obstetrics and gynecology. 2018 Aug:132(2):e64-e66. doi: 10.1097/AOG.0000000000002757. Epub     [PubMed PMID: 30045212]

Level 3 (low-level) evidence


. ACOG Committee Opinion No. 443: Air travel during pregnancy. Obstetrics and gynecology. 2009 Oct:114(4):954. doi: 10.1097/AOG.0b013e3181bd1325. Epub     [PubMed PMID: 19888065]


. ACOG educational bulletin. Obstetric aspects of trauma management. Number 251, September 1998 (replaces Number 151, January 1991, and Number 161, November 1991). American College of Obstetricians and Gynecologists. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 1999 Jan:64(1):87-94     [PubMed PMID: 10190681]

Level 1 (high-level) evidence